Bellerophon Therapeutics Statistics
Total Valuation
BLPH has a market cap or net worth of $665,453. The enterprise value is -$3.72 million.
| Market Cap | 665,453 |
| Enterprise Value | -3.72M |
Important Dates
The last earnings date was Monday, November 13, 2023, before market open.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
BLPH has 12.23 million shares outstanding. The number of shares has increased by 28.15% in one year.
| Shares Outstanding | 12.23M |
| Shares Change (YoY) | +28.15% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 15.03% |
| Owned by Institutions (%) | 10.47% |
| Float | 10.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.12 |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.96, with zero debt.
| Current Ratio | 3.96 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 7.53 |
Financial Efficiency
Return on equity (ROE) is -313.46% and return on invested capital (ROIC) is -296.40%.
| Return on Equity (ROE) | -313.46% |
| Return on Assets (ROA) | -234.38% |
| Return on Capital (ROIC) | -296.40% |
| Revenue Per Employee | $313,333 |
| Profits Per Employee | -$648,333 |
| Employee Count | 18 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BLPH has paid $1.03 million in taxes.
| Income Tax | 1.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.45% in the last 52 weeks. The beta is 0.68, so BLPH's price volatility has been lower than the market average.
| Beta (1Y) | 0.68 |
| 52-Week Price Change | -99.45% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 48.20 |
| Average Volume (30 Days) | 45,992 |
Short Selling Information
The latest short interest is 90,446, so 0.74% of the outstanding shares have been sold short.
| Short Interest | 90,446 |
| Short Previous Month | 197,473 |
| Short % of Shares Out | 0.74% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 1.26 |
Income Statement
In the last 12 months, BLPH had revenue of $5.64 million and -$11.67 million in losses. Loss per share was -$1.09.
| Revenue | 5.64M |
| Gross Profit | 5.64M |
| Operating Income | -11.04M |
| Pretax Income | -10.53M |
| Net Income | -11.67M |
| EBITDA | -11.17M |
| EBIT | -11.18M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $4.38 million in cash and no debt, giving a net cash position of $4.38 million or $0.36 per share.
| Cash & Cash Equivalents | 4.38M |
| Total Debt | n/a |
| Net Cash | 4.38M |
| Net Cash Per Share | $0.36 |
| Equity / Book Value | 3.72M |
| Book Value Per Share | 0.30 |
| Working Capital | 3.72M |
Cash Flow
| Operating Cash Flow | -12.34M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.34M |
| FCF Per Share | -$1.01 |
Margins
Gross margin is 100.00%, with operating and profit margins of -195.66% and -206.91%.
| Gross Margin | 100.00% |
| Operating Margin | -195.66% |
| Pretax Margin | -186.70% |
| Profit Margin | -206.91% |
| EBITDA Margin | -198.05% |
| EBIT Margin | -198.16% |
| FCF Margin | -218.78% |
Dividends & Yields
BLPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.15% |
| Shareholder Yield | -28.15% |
| Earnings Yield | -1,753.69% |
| FCF Yield | -1,854.23% |
Analyst Forecast
The average price target for BLPH is $2.00, which is 3,576.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.00 |
| Price Target Difference | 3,576.47% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 10, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 10, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
BLPH has an Altman Z-Score of -77.13 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -77.13 |
| Piotroski F-Score | 1 |